Crab clps

This is the biggest 48 hours of the year for tech. Google, Microsoft, Meta, Amazon — all four print this week, RIGHT after OpenAI's CFO admitted the company isn't ready to IPO and missed user/revenue targets. The setup is loaded.

$Alphabet(GOOGL.US) just dropped a new tech called TurboQuant 🤯 — it cuts memory usage during AI inference down to one-sixth while actually boosting performance. The market’s knee-jerk reaction: does this mean we won’t need as many memory chips after all? 🤔

But stepping back, this feels more like short-term trading noise than a shift in the fundamentals. For one, the tech mainly optimizes inference-stage cache — it doesn’t directly reduce demand for training or core storage. And with AI still in explosive growth mode📈, compute and memory demand are expanding together. One compression algorithm isn’t going to cause a demand collapse💀

Personally, I see this kind of “tech shock” as more of a volatility driver than a trend-changer. In the memory space, sentiment rules the short term, but the medium-to-long term story still comes down to the AI demand curve. This looks more like a shakeout on negative news than a broken thesis🧹

The $700B data center commitment confirms AI infra spending isn't slowing

The chip rally (Intel, AMD, Micron all +6%) confirms AI demand is broadening beyond just GPUs to CPUs, memory, and servers

📣 (Potential Next Opportunity) A-Share Analysis 👀

Nvidia’s $4B move signals a strong push to fuel the AI ecosystem with its massive cash reserves.

Next likely CPO bottleneck: optical packaging equipment suppliers. Given Nvidia’s track record of removing supply chain constraints, Robotec (HK IPO-bound) could be a prime candidate for cornerstone investment, as it supplies core equipment to Lumentum.

While Nvidia recently injected $2B each into Lumentum and Coherent, equipment makers may receive smaller checks. Still, given their critical role in scaling CPO capacity, a $300–500M cornerstone investment seems plausible—enough to signal commitment and support CapEx needs.

Key takeaways:

$NVIDIA(NVDA.US) : Locking in key supply chains, removing optical bottlenecks for next-gen AI infra (GB200, SuperPod). Long-term positive for AI dominance.

$Fabrinet(FN.US) : Top optical packaging & precision mfg services for Lumentum/Coherent. Direct beneficiary of capacity expansion.

$Broadcom(AVGO.US) : Leader in CPO switch silicon, core supplier to Nvidia and cloud giants. CPO acceleration = direct demand boost.

⚠️ Risk note: Tech stocks are highly volatile. Near-term positives may be priced in. Watch for pullback risk.

$Coreweave(CRWV.US) finally getting the recognition it deserves. That $8.5B Meta-backed loan is a game changer. When your customer (META) guarantees your debt, you know the contracts are real. The 142 亿 + 50 亿 deal combo is massive. 🚀

James Cameron letter to senator: $Netflix(NFLX.US) -WBD deal "disastrous" for theaters . Mark Ruffalo fires back: so Paramount is fine? Hollywood eating itself. NFLX at $76, I'm just watching.

AMZN down 20%?! It’s a chance?

What I find interesting about $Coreweave(CRWV.US) is that it represents the computing power leasing/infrastructure sector within the AI ​​industry chain, rather than directly building models.

JPM cut 43% of $SPDR Gold Shares(GLD.US) position in Q4 . BNP cut 20%. Traditional wealth firms like Levin Capital also trimming 10-15% . Yet GLD holdings just hit 1081.32 tonnes, up 2t today . Institutions selling, retail buying. Who‘s gonna be right this time? 🐙

$Coca Cola(KO.US)reports before open tonight. The stock’s been on a nice run — up like 12% in a month and even hit $79+ last week. Kinda makes you wonder if all the good news is already priced in 😅

They’re expected to post around $0.57 EPS and just over $12B in revenue. Honestly, the number itself feels almost secondary — KO beats almost every quarter anyway. What I’m really looking for:

1. Guidance — new CEO stepping in soon, and with all the talk about consumer spending getting shaky, what’s the outlook for ‘26?

2. Dividend hike? They’re a Dividend King… could they sweeten the payout again?

3. Pricing power — can they keep passing on costs without losing customers? Pepsi’s been doing pretty well lately, so the pressure is on.

4. That Costco switch back to Coke — did it actually boost sales?

Also, side note: they just killed their frozen drinks line in the US. Not a huge shock, but makes you think they’re really pushing juice and core sodas now.

Analysts still like it (avg target around $87), and Wells Fargo just bumped their target up. But with the stock near highs, a “beat and raise” might already be expected.

$Unitedhealth(UNH.US) recent stock performance has been quite mixed. On one hand, it boasts the strong fundamentals and competitive advantage of being a leading health insurance provider; on the other hand, the market is concerned about rising Medicare Advantage costs and regulatory pressures. The latest financial report shows a significant increase in the healthcare cost ratio, indicating that utilization rates have indeed returned, releasing pent-up demand after the pandemic, which puts short-term pressure on profit margins. However, in the long term, the US healthcare system is highly dependent on insurance management, and UnitedHealth's Optum business is increasingly resembling a technology + healthcare management platform, suggesting some short-term panic pricing in the market. Now, after the valuation pullback, it's actually approaching its value range.

Here's a summary of my stock holdings: $Unitedhealth(UNH.US) , cost basis 275, attempted to buy at the bottom but failed. $BitMine Immersion Tech(BMNR.US) , cost basis 26, position is a bit heavy, planning to reduce holdings.$Coreweave(CRWV.US), entered around mid-range, missed the early explosive rally. Stock surged on AI hype and Nvidia backing, but volatility is extreme.

$Oracle(ORCL.US)down another 5%... this software rout is brutal. Thinking it's time to average down or just cut losses?

$Circle(CRCL.US) Another pre-market gap up? I hope I have the opportunity to reduce the cost to below 60.

Watching google’s cloud margins closely. That's the real efficiency test

UnitedHealth shares sank on disappointing Medicare Advantage rate news and softer revenue outlook, forcing many investors to question the sustainability of its managed care margins.

Big Tech earnings this week. Will Apple finally give us a clear AI revenue number?

$Coreweave(CRWV.US) premarket +almost 3%, tonight can hit 100?